AAAAAA
Results: 1-25/31
Authors:
GOETZ CG
VOGEL C
TANNER CM
STEBBINS GT
Citation: Cg. Goetz et al., EARLY DOPAMINERGIC DRUG-INDUCED HALLUCINATIONS IN PARKINSONIAN-PATIENTS, Neurology, 51(3), 1998, pp. 811-814
Authors:
CHAN P
TANNER CM
JIANG X
FORNO LS
DIMONTE DA
LANGSTON JW
Citation: P. Chan et al., ABSENCE OF MUTATION IN THE ALPHA-SYNUCLEIN GENE IN CLINICALLY-DEFINEDAND PATHOLOGICALLY-DEFINED PARKINSONS-DISEASE, Neurology, 50(4), 1998, pp. 20003-20003
Authors:
NELSON LM
CHAN P
TANNER CM
VANDENEEDEN SK
Citation: Lm. Nelson et al., ABSENCE OF THE ALPHA-SYNUCLEIN GENE MISSENSE MUTATION (G(209)A) IN 40PATIENTS WITH A FAMILY HISTORY OF PARKINSONS-DISEASE, Neurology, 50(4), 1998, pp. 20004-20004
Authors:
TANNER CM
GOLDMAN SM
LANGSTON JW
OTTMAN R
ELLENBERG J
Citation: Cm. Tanner et al., SMOKING AND RISK OF PARKINSONS-DISEASE (PD) IN TWINS DISCORDANT FOR PARKINSONS-DISEASE, Neurology, 50(4), 1998, pp. 60004-60004
Authors:
VANDENEEDEN SK
NELSON LM
TANNER CM
Citation: Sk. Vandeneeden et al., FIRST YEAR RESOURCE UTILIZATION AMONG PARKINSONS-DISEASE PATIENTS ANDMATCHED CONTROLS IN A MANAGED CARE SETTING, Neurology, 50(4), 1998, pp. 60006-60006
Authors:
CHAN P
JIANG X
FORNO LS
DIMONTE DA
TANNER CM
LANGSTON JW
Citation: P. Chan et al., ABSENCE OF MUTATIONS IN THE CODING REGION OF THE ALPHA-SYNUCLEIN GENEIN PATHOLOGICALLY PROVEN PARKINSONS-DISEASE, Neurology, 50(4), 1998, pp. 1136-1137
Authors:
CHAN P
TANNER CM
JIANG X
LANGSTON JW
Citation: P. Chan et al., FAILURE TO FIND THE ALPHA-SYNUCLEIN GENE MISSENSE MUTATION (G(209)A) IN 100 PATIENTS WITH YOUNGER ONSET PARKINSONS-DISEASE, Neurology, 50(2), 1998, pp. 513-514
Authors:
TANNER CM
GOLDMAN SM
Citation: Cm. Tanner et Sm. Goldman, EPIDEMIOLOGY OF TOURETTE-SYNDROME, Neurologic clinics, 15(2), 1997, pp. 395
Authors:
SHALE HM
BURKHARD PR
TAMAS LB
TETRUD JW
TANNER CM
LANGSTON JW
Citation: Hm. Shale et al., EFFECTS OF POSTEROVENTRAL PALLIDOTOMY ON MOTOR FUNCTION AND QUALITY-OF-LIFE IN PATIENTS WITH ADVANCED PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 4102-4102
Authors:
TANNER CM
OTTMAN R
ELLENBERG JH
GOLDMAN SM
MAYEUX R
CHAN P
LANGSTON JW
Citation: Cm. Tanner et al., PARKINSONS-DISEASE (PD) CONCORDANCE IN ELDERLY MALE MONOZYGOTIC (MZ) AND DIZYGOTIC (DZ) TWINS, Neurology, 48(3), 1997, pp. 42002-42002
Authors:
NELSON LM
VANDENEEDEN SK
TANNER CM
FROSS RD
BERNSTEIN AL
ROSA S
PAROUBECK LA
SOREL ME
MILLER MK
Citation: Lm. Nelson et al., INCIDENCE OF IDIOPATHIC PARKINSONS-DISEASE (PD) IN A HEALTH MAINTENANCE ORGANIZATION (HMO) - VARIATIONS BY AGE, GENDER AND RACE ETHNICITY/, Neurology, 48(3), 1997, pp. 42005-42005
Authors:
KURTH MC
ADLER CH
STHILAIRE M
SINGER C
WATERS C
LEWITT P
CHERNIK DA
DORFLINGER EE
YOO K
LIEBERMAN AN
BREWER M
SAINTHILAIRE M
PERY LM
THOMAS C
TURPIN L
OBRIEN CF
SEEBERGER LC
DUNCAN KL
CAVINESS JN
DOUGLAS M
WHEELER K
RILEY D
RAINEY P
TANNER CM
KELKER K
LEWIS P
TROSCH RM
MISTURA KL
MONTGOMERY EB
LINDSEY B
WEINER W
SHULMAN LM
SHELDON C
WATERS CH
WELSH M
TRUGMAN JM
LANDOW ER
PEDDER SCJ
SHIMON GS
MAGNI G
Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE EXPERIENCING MOTOR FLUCTUATIONS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Neurology, 48(1), 1997, pp. 81-87
Authors:
TANNER CM
Citation: Cm. Tanner, EARLY INTERVENTION IN PARKINSONS-DISEASE - EPIDEMIOLOGIC CONSIDERATIONS, Annals of epidemiology, 6(5), 1996, pp. 438-441
Authors:
TANNER CM
GOLDMAN SM
Citation: Cm. Tanner et Sm. Goldman, EPIDEMIOLOGY OF PARKINSONS-DISEASE, Neurologic clinics, 14(2), 1996, pp. 317
Authors:
SANDY MS
ARMSTRONG M
TANNER CM
DALY AK
DIMONTE DA
LANGSTON JW
IDLE JR
Citation: Ms. Sandy et al., CYP2D6 ALLELIC FREQUENCIES IN YOUNG-ONSET PARKINSONS-DISEASE, Neurology, 47(1), 1996, pp. 225-230
Authors:
CHAN P
SANDY MS
TANNER CM
DIMONTE D
LANGSTON JW
Citation: P. Chan et al., ALLELES OF XENOBIOTIC-METABOLIZING ENZYMES ARE ASSOCIATED WITH AN INCREASED RISK FOR PARKINSONS-DISEASE, Neurology, 46(2), 1996, pp. 31003-31003
Authors:
GILLEY DW
WILSON RS
FLEISCHMAN DA
HARRISON DW
GOETZ CG
TANNER CM
Citation: Dw. Gilley et al., IMPACT OF ALZHEIMERS-TYPE DEMENTIA AND INFORMATION SOURCE ON THE ASSESSMENT OF DEPRESSION, Psychological assessment, 7(1), 1995, pp. 42-48
Authors:
MCDERMOTT MP
JANKOVIC J
CARTER J
FAHN S
GAUTHIER S
GOETZ CG
GOLBE LI
KOLLER W
LANG AE
OLANOW CW
SHOULSON I
STERN MB
TANNER CM
WEINER WJ
Citation: Mp. Mcdermott et al., FACTORS PREDICTIVE OF THE NEED FOR LEVODOPA THERAPY IN EARLY, UNTREATED PARKINSONS-DISEASE, Archives of neurology, 52(6), 1995, pp. 565-570
Authors:
CHAN P
SHULTS CW
TANNER CM
FINK JS
KURTH M
MAREK KL
ELMER LW
Citation: P. Chan et al., USE OF A CLINICAL-TRIALS POPULATION IN GENETIC RESEARCH, American journal of human genetics, 57(4), 1995, pp. 1835-1835
Authors:
TANNER CM
GOLDMAN SM
Citation: Cm. Tanner et Sm. Goldman, EPIDEMIOLOGY OF MOVEMENT-DISORDERS, Current opinion in neurology, 7(4), 1994, pp. 340-345
Authors:
KURLAN R
TANNER CM
GOETZ C
SUTTON J
LICHTER D
CARVEY P
DEELEY C
CUI L
IRVINE C
MCDERMOTT MP
Citation: R. Kurlan et al., LEVODOPA DRUG HOLIDAY VERSUS DRUG-DOSAGE REDUCTION IN PARKINSONS-DISEASE, Clinical neuropharmacology, 17(2), 1994, pp. 117-127
Authors:
TANNER CM
ELLENBERG JH
MAYEUX R
OTTMAN R
LANGSTON W
Citation: Cm. Tanner et al., A SENSITIVE AND SPECIFIC SCREENING METHOD FOR PARKINSONS-DISEASE (PD), Neurology, 44(4), 1994, pp. 10000136-10000136
Authors:
TANNER CM
MELAMED E
LEES AJ
Citation: Cm. Tanner et al., MANAGING MOTOR FLUCTUATIONS, DYSKINESIAS, AND OTHER ADVERSE-EFFECTS IN PARKINSONS-DISEASE, Neurology, 44(3), 1994, pp. 12-16
Authors:
DIMONTE DA
SANDY MS
JEWELL SA
ADORNATO B
TANNER CM
LANGSTON JW
Citation: Da. Dimonte et al., OXIDATIVE-PHOSPHORYLATION BY INTACT MUSCLE MITOCHONDRIA IN PARKINSONS-DISEASE, Neurodegeneration, 2(4), 1993, pp. 275-281
POLYSOMNOGRAPHIC SLEEP MEASURES IN PARKINSONS-DISEASE PATIENTS WITH TREATMENT-INDUCED HALLUCINATIONS
Authors:
COMELLA CL
TANNER CM
RISTANOVIC RK
Citation: Cl. Comella et al., POLYSOMNOGRAPHIC SLEEP MEASURES IN PARKINSONS-DISEASE PATIENTS WITH TREATMENT-INDUCED HALLUCINATIONS, Annals of neurology, 34(5), 1993, pp. 710-714